Solid lipid nanoparticles and their application in the treatment of bacterial infectious diseases

Biomed Pharmacother. 2024 May:174:116433. doi: 10.1016/j.biopha.2024.116433. Epub 2024 Mar 19.

Abstract

Nano pharmacology is considered an effective, safe, and applicable approach for drug delivery applications. Solid lipid nanoparticle (SLNs) colloids contain biocompatible lipids which are capable of encapsulating and maintaining hydrophilic or hydrophobic drugs in the solid matrix followed by releasing the drug in a sustained manner in the target site. SLNs have more promising potential than other drug delivery systems for various purposes. Nowadays, the SLNs are used as a carrier for antibiotics, chemotherapeutic drugs, nucleic acids, herbal compounds, etc. The SLNs have been widely applied in biomedicine because of their non-toxicity, biocompatibility, and simple production procedures. In this review, the complications related to the optimization, preparation process, routes of transplantation, uptake and delivery system, and release of the loaded drug along with the advantages of SLNs as therapeutic agents were discussed.

Keywords: Bacterial infectious; Drug delivery systems; Solid lipid nanoparticles.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Infections* / drug therapy
  • Bacterial Infections* / microbiology
  • Drug Carriers / chemistry
  • Drug Delivery Systems / methods
  • Humans
  • Lipids* / chemistry
  • Liposomes*
  • Nanoparticles* / chemistry

Substances

  • Lipids
  • Anti-Bacterial Agents
  • Drug Carriers
  • Lipid Nanoparticles
  • Liposomes